Home
>
National Drug Code (NDC)
>
Nipent
Nipent - 0409-0801-01 - (PENTOSTATIN)
Drug Information of Nipent
| Product NDC: | 0409-0801 |
| Proprietary Name: | Nipent |
| Non Proprietary Name: | PENTOSTATIN |
| Active Ingredient(s): | 2 mg/mL & nbsp; PENTOSTATIN |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nipent
| Product NDC: | 0409-0801 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020122 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20091102 |
Package Information of Nipent
| Package NDC: | 0409-0801-01 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0801-01) > 5 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Nipent
| NDC Code | 0409-0801-01 |
| Proprietary Name | Nipent |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0801-01) > 5 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0409-0801 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PENTOSTATIN |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20091102 |
| Marketing Category Name | NDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | PENTOSTATIN |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
